Demant AS

DEMANT: XCSE (DNK)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
DKK 653.00FyxdkwnWkgshrzt

Demant: Maintaining FVE as Hearing Healthcare Offsets Negative Communications Growth in Q1

We are maintaining our DKK 240 fair value estimate for narrow-moat Demant as it raises fiscal-year 2023 guidance on the back of a strong first quarter. With first-quarter revenue up 14% organically, fiscal-year revenue guidance is raised to 6%-10% and EBIT raised by DKK 200 million to DKK 3.8 billion-DKK 4.2 billion. Hearing healthcare grew 16% organically year over year with another 4% in growth supported by the acquisition of Sheng Wang, showing stronger continuing COVID-19-recovery than anticipated. We currently view shares as fairly valued.

Sponsor Center